Design Therapeutics provides corporate highlights, anticipated milestones
Design has initiated dosing in a Phase 1 clinical trial in healthy volunteers in Australia to evaluate the safety and ...
Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results
Initiated Phase 1 Single Ascending Dose Trial of DT-216P2 in Healthy Volunteers; Friedreich Ataxia (FA) Patient Dosing to Begin in mid-2025Dosing ...
247Sports.com10d
DT Daniel Howard has full spring slate planned
Chicago Lane Tech's Daniel Howard is a quick, disruptive three-tech who has six offers including four from Power Four schools. Kansas State is the most recent, offering on Monday, and the Wildcats ...